EUVIMED · CrossrefZeitschrift
Hemoglobin
ISSN 0363-0269 · Informa UK Limited
Neueste Artikel
Evaluation of the Efficacy and Safety of Alternating Chelation Therapy in Transfusion-Dependent Thalassemia
Negotiating Genetic Risk: Tunisian Adolescents’ Attitudes Toward Marriage, Reproduction, and Hereditary Blood Disorders
Congenital Methemoglobinemia in a Vietnamese Adolescent: A Dyshemoglobinemia with Diagnostic Challenges, Literature Review, and Diagnostic Algorithm
Probable Deferasirox-Associated Acute-on-Chronic Liver Failure in Non–Transfusion-Dependent β-Thalassemia with Iron-Related Cirrhosis: A Case Report
Hemoglobin Fukuyama: First Report of a Rare β-Chain Variant from India
Genotype–Phenotype Spectrum, Socio-Demographic Drivers, and the Protective Impact of Fetal Hemoglobin in Sickle Cell Disease: A Cross-Sectional Analysis from West Bengal, India
Hemoglobin Evans Associated with HBA1 Mutation: First Report from Rosario, Argentina
Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan
Diagnosis and Treatment of Alpha Thalassemia Major
De Novo Occurrence of Hb Chile [β28(B10) Leu→Met] in a Korean Boy with Methemoglobinemia
The Validation of Whole β-Globin Gene Sequencing for Detecting β-Thalassemia Mutations Found in Thailand Using Next-Generation Sequencing (NGS)
Two Novel α-Thalassemia Mutations CD 39 -C [Thr > Pro] and CD 109 ACC > CCC [Thr > Pro] Identified in Two Chinese Families: A Case Report
Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review
A New Mutation, Hb A 2 -Canakkale [δ10(A7)Ala→Val; HBD : c.32C>T], and Other Well-Known δ Variants Identified in a Selected Cohort with Low Hb A 2 Levels
Thalassemia in India
Thalassemia in Thailand
An Evaluation for the Causes of Reduced Hb A 2 and the Molecular Characterization of HBD Variants in Hong Kong
Quality of Life and Related Factors in β-Thalassemia Patients
Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient–Physician Partnerships to Improve Care
Molecular Characterization of β- and α-Globin Gene Mutations in Individuals with Borderline Hb A 2 Levels
Hematological Characteristics of β-Globin Gene Mutation –50 (G>A) ( HBB : c.-100G>A) Carriers in Mainland China
Novel α 0 -Thalassemia Deletion Identified in an Indian Infant with Hb H Disease
Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience
A Krüppel-Like Factor 1 Gene Mutation Ameliorates the Severity of β -Thalassemia: A Case Report
The Sub-Phenotypes of Sickle Cell Disease in Kuwait
Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India
Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Anemia and Severe Acute Chest Syndrome
Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β -Thalassemia Intermedia Patients
Fetal Anemia and Hydrops Fetalis Associated with Homozygous Hb Constant Spring ( HBA2 : c.427T > C)
Jahrgänge
2026 · 702025 · 752024 · 692023 · 412022 · 712021 · 832020 · 902019 · 1272018 · 792017 · 742016 · 1012015 · 972014 · 992013 · 662012 · 822011 · 802010 · 782009 · 1032008 · 742007 · 642006 · 602005 · 572004 · 562003 · 462002 · 582001 · 532000 · 501999 · 511998 · 651997 · 511996 · 391995 · 511994 · 521993 · 611992 · 611991 · 571990 · 661989 · 821988 · 881987 · 70
EUVIMED